businesses
9Bio Therapeutics
9Bio Therapeutics – Engineering Biological Possibilities
Biotechnologies Aramis
Aramis Biotechnologies | Plant-based vaccine technology
Molecular Forecaster
Homepage – Molecular Forecaster
Project of 2 056 964 $ over 2 years
- Supported by CQDM through:
Ministère de l’Économie, de l’Innovation et de l’Énergie du Québec (MEIE) - By co-funding partners:
9Bio Thérapeutiques, Biotechnologies Aramis, Molecular Forecaster - And by project partner:
IVADO
Project summary
This collaborative research project brings together three Quebec-based companies (9Bio Therapeutics, Molecular Forecaster and Aramis Biotechnologies) and academic partners, dedicated to using artificial intelligence (AI) to develop a new combinatorial approach to solid tumours. Aware of the common side effects associated with current treatments, the companies’ priority is to offer innovative, better-tolerated combinatorial therapies aimed at improving survival and quality of life for cancer patients. The companies are committed to making these therapeutic advances accessible to a wide range of patients, including those who may be forced to discontinue treatment due to tolerability issues. Guided by AI, this project optimizes the structure of small molecules and protein compounds to accelerate drug development. In addition, the participation of a company specializing in the plant-based production of vaccines and biotherapeutics, reinforces the feasibility and therapeutic potential of their new drug combination.
